Document is current
Any future updates will be listed below
-
Authors
Yu, Ruofan
Roseman, Shelby
Siegenfeld, Allison P.
Gardner, Zachary https://orcid.org/0000-0003-1905-8686
Nguyen, Son C. https://orcid.org/0000-0003-2187-1027
Tran, Khoa A.
Joyce, Eric F.
Jain, Rajan
Liau, Brian B.
Krantz, Ian D.
Alexander, Katherine A. https://orcid.org/0000-0001-6418-6615
Berger, Shelley L. https://orcid.org/0000-0001-5398-4400
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 3 December 2024
First Online: 21 February 2025
Competing interests
: B.B.L. has received research funding from Eisai and AstraZeneca and is a shareholder and member of the scientific advisory board of Light Horse Therapeutics. The remaining authors declare no competing interests.
